OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide

Published Date: 01/11/2010
Category: Therapies & Markets

Research Report Decription

OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country.
• Includes a five-year forecast of the industry

Key Questions Answered:

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Companies Mentioned:

Abbott Laboratories, Bayer AG, Boehringer Ingelheim GmbH, Chengdu Rosun Antiseptic Pharmaceutical Co., Ltd, Cipla Ltd, GlaxoSmithKline, Johnson & Johnson, Novartis AG,  Pharma Natura (Pty) Ltd: , Sanofi-Aventis, Weleda Group

Paper Highlights:

• The Top 5 Emerging countries contributed $17658.8 million to the global OTC Pharmaceuticals industry in 2009, with a CAGR of 7% between 2005 and 2009
• China is the leading country among the Top 5 emerging nations, with market revenues of $9,811. million in 2009.
• The China is expected to lead the otc pharmaceuticals industry in the Top five emerging nations, with a value of $13,449.9 in 2014